In Brief: Novartis, Abbott Earnings; Using mL Cuts Mis-Dosing; Labels Need Proprietary Blend, Capsule Ingredients

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".